Maximus (NYSE:MMS) Issues Earnings Results

Maximus (NYSE:MMS) released its quarterly earnings results on Thursday. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22, Zacks reports. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Maximus updated its FY 2025 guidance to 5.900-6.200 EPS.

Maximus Stock Down 0.2 %

Shares of MMS opened at $69.86 on Friday. The firm has a market cap of $3.99 billion, a P/E ratio of 15.02 and a beta of 0.72. Maximus has a 1 year low of $68.30 and a 1 year high of $93.97. The stock has a 50 day simple moving average of $74.73 and a two-hundred day simple moving average of $83.38. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.49.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Saturday, February 15th will be given a $0.30 dividend. The ex-dividend date is Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.72%. Maximus’s payout ratio is 25.81%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. StockNews.com raised shares of Maximus from a “hold” rating to a “buy” rating in a research note on Thursday. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a report on Thursday, January 2nd.

Insiders Place Their Bets

In related news, insider Michelle F. Link sold 2,208 shares of the firm’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the transaction, the insider now directly owns 6,567 shares in the company, valued at $484,841.61. This trade represents a 25.16 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Bruce Caswell acquired 3,500 shares of the stock in a transaction on Tuesday, December 17th. The stock was bought at an average price of $70.64 per share, with a total value of $247,240.00. Following the transaction, the chief executive officer now directly owns 275,929 shares of the company’s stock, valued at approximately $19,491,624.56. The trade was a 1.28 % increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders have acquired 7,063 shares of company stock valued at $502,017. 1.60% of the stock is currently owned by corporate insiders.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.